---
title: "ANG Lifesciences India Ltd (540694) — Share Price, Financials & Analysis"
symbol: "540694"
company: "ANG Lifesciences India Ltd"
canonical: "https://tapetide.com/stocks/540694"
isin: "INE236W01016"
nse_symbol: "ANGLIFESCIENCESINDIALTD"
bse_code: "540694"
sector: "Healthcare"
industry: "Pharmaceuticals"
market_cap_cr: 46.8
generated_at: "2026-09-13T19:29:15.891Z"
---

# ANG Lifesciences India Ltd (540694)

Canonical page: https://tapetide.com/stocks/540694

## Company

- **NSE Symbol:** ANGLIFESCIENCESINDIALTD
- **BSE Code:** 540694
- **ISIN:** INE236W01016
- **Sector:** Healthcare
- **Industry:** Pharmaceuticals
- **Macro Sector:** Healthcare
- **Stock Type:** EQUITY
- **Listed Since:** 2017-09-08
- **Face Value:** ₹10
- **F&O Eligible:** No
- **Website:** anglifesciences.com

## About

Incorporated in 2006, ANG Lifesciences 
India Ltd is in the business of pharmaceuticals products & formulations, and packaging and printing.[1]

## Latest Price

## Key Fundamentals

Observed at 2026-09-11T04:38:21.442327Z.

- **Market Cap:** ₹46.8 Cr
- **Classification:** Microcap
- **P/E (reported):** -3.5
- **EPS (TTM):** ₹-10.21
- **Book Value:** ₹40.5
- **Price to Book:** 0.88
- **Dividend Yield:** 2.79%
- **ROE:** -19.4%
- **ROCE:** -8.13%
- **Debt to Equity:** 1.49
- **Revenue (yearly):** ₹92.89 Cr
- **Net Income:** ₹-13.01 Cr
- **EBITDA:** ₹0.7 Cr
- **52-Week High:** ₹49.69
- **52-Week Low:** ₹17.63
- **RSI (14):** 66.39

## Tapetide Score

- **Score:** 56 / 100
- **Score date:** 2026-09-04
- **Archetype:** Average Quality, Undemanding Price
- **What it means:** The financials sit mid-range rather than strong, and the multiple is not demanding. Nothing here stands out in either direction, so the read comes down to which single pillar you weight most and whether the next results move it off the middle.
- **Pillar profile:** Quality: Average · Valuation: Cheap · Momentum: Rising
- **Percentile:** 74.1 (of 4473 scored stocks)
- **Confidence:** 88%
- **Data coverage:** 76%

| Pillar | Score | Weight |
| --- | --- | --- |
| financial health | 15.45 | 9% |
| growth | 18.42 | 9% |
| momentum | 90.94 | 12% |
| ownership | 50 | 24% |
| quality | 57.68 | 22% |
| valuation | 89.7 | 24% |

The Tapetide Score is decision-support only, not investment advice.

## Key Insights

### Strengths

- Stock is trading at 0.89 times its book value

### Weaknesses

- Company has low interest coverage ratio.
- The company has delivered a poor sales growth of -9.66% over past five years.
- Company has a low return on equity of -15.1% over last 3 years.
- Promoters have pledged 44.9% of their holding.
- Company has high debtors of 267 days.

## Growth Rates

| Metric | QoQ | 1Y | 3Y | 5Y |
| --- | --- | --- | --- | --- |
| cash flow growth | — | 97.26% | -100.99% | -101.94% |
| ebitda margin growth | -164.29% | -388.46% | -89.36% | -96.1% |
| net income growth | -200% | 4.92% | 28.81% | -132.28% |
| revenue growth | -35.02% | -2.12% | -25% | -10% |
| roce | -409.26% | — | -164.68% | 13.68% |
| roe | 207.25% | 45.86% | -11% | — |

## Financial Statements

### Quarterly Results

All figures in ₹ crore unless the row name says otherwise.

| Item | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Sales | 33.26 | 18.55 | 37.84 | 18.41 | 32.88 | 24.73 | 16.82 | 24.6 | 26.05 | 18.73 | 23.5 | 15.3 |
| Expenses | 31.6 | 20.46 | 34.48 | 20.12 | 30.6 | 26.88 | 17.52 | 23.95 | 25.97 | 21.41 | 20.82 | 17.25 |
| Operating Profit | 1.66 | -1.91 | 3.36 | -1.71 | 2.28 | -2.15 | -0.7 | 0.65 | 0.08 | -2.68 | 2.68 | -1.95 |
| OPM % | 4.99 | -10.3 | 8.88 | -9.29 | 6.93 | -8.69 | -4.16 | 2.64 | 0.31 | -14.31 | 11.4 | -12.75 |
| Other Income | 0.22 | -0.03 | -1.55 | 1.28 | 0.35 | -0.27 | 0.65 | 0.09 | 0.12 | 0.16 | 0.17 | 0.11 |
| Interest | 2.29 | 2.51 | 3.84 | 2.08 | 2.18 | 2 | 2.42 | 1.94 | 1.89 | 1.93 | 2.18 | 2.24 |
| Depreciation | 2.22 | 1.91 | 2.05 | 1.63 | 1.74 | 1.96 | 1.42 | 1.53 | 1.52 | 1.51 | 1.77 | 1.5 |
| Profit before tax | -2.63 | -6.36 | -4.08 | -4.14 | -1.29 | -6.38 | -3.89 | -2.73 | -3.21 | -5.96 | -1.1 | -5.58 |
| Tax % | -12.17 | -6.92 | -10.54 | -25.85 | 62.02 | -18.65 | -47.04 | -26.74 | -8.41 | -20.3 | 25.45 | -24.01 |
| Net Profit | -2.32 | -5.93 | -3.65 | -3.07 | -2.09 | -5.19 | -2.06 | -2.01 | -2.95 | -4.75 | -1.38 | -4.24 |
| EPS in Rs | -1.78 | -4.54 | -2.8 | -2.35 | -1.6 | -3.97 | -1.58 | -1.54 | -2.26 | -3.64 | -1.06 | -3.25 |

### Profit & Loss

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Sales | 154 | 354 | 220 | 145 | 93 | 93 | 84 |
| Expenses | 140 | 286 | 205 | 135 | 94 | 92 | 85 |
| Operating Profit | 14 | 68 | 15 | 10 | -1 | 1 | -2 |
| OPM % | 9 | 19 | 7 | 7 | -1.6 | 0.8 | -2.2 |
| Other Income | 1 | 1 | 10 | -1 | 2 | 1 | 1 |
| Interest | 4 | 9 | 12 | 11 | 9 | 8 | 8 |
| Depreciation | 1 | 6 | 9 | 8 | 7 | 6 | 6 |
| Profit before tax | 10 | 54 | 3 | -11 | -16 | -13 | -16 |
| Tax % | 31 | 25 | 110 | -5 | -21 | -15 | — |
| Net Profit | 7 | 40 | 0 | -10 | -12 | -11 | -13 |
| EPS in Rs | 5.26 | 31.02 | -0.2 | -7.77 | -9.5 | -8.49 | -10.21 |
| Dividend Payout % | 0 | 3 | 0 | 0 | 0 | 0 | — |

### Balance Sheet

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- |
| Equity Capital | — | 10 | 13 | 13 | 13 | 13 |
| Reserves | — | 73 | 73 | 63 | 51 | 40 |
| Borrowings | — | 77 | 71 | 73 | 83 | 79 |
| Other Liabilities | — | 130 | 119 | 92 | 82 | 77 |
| Total Liabilities | — | 290 | 276 | 241 | 230 | 209 |
| Fixed Assets | — | 93 | 88 | 58 | 57 | 51 |
| CWIP | — | 0 | 0 | 0 | 0 | 0 |
| Investments | — | 0 | 0 | 0 | 0 | 0 |
| Other Assets | — | 198 | 188 | 183 | 172 | 158 |
| Total Assets | — | 290 | 276 | 241 | 230 | 209 |

### Cash Flow

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- |
| Cash from Operating Activity | — | 25 | 26 | -9 | 0 | 11 |
| Cash from Investing Activity | — | -44 | -9 | 20 | -2 | 1 |
| Cash from Financing Activity | — | 20 | -17 | -10 | 2 | -12 |
| Net Cash Flow | — | 0 | 0 | 0 | 0 | 0 |
| Free Cash Flow | — | -17 | 16 | 9 | -4 | 11 |
| CFO/OP | — | 37 | 202 | 39 | -272 | 1559 |

### Ratios

| Item | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- |
| Debtor Days | — | 105 | 138 | 184 | 262 | 267 |
| Inventory Days | — | 59 | 118 | 183 | 331 | 279 |
| Days Payable | — | 113 | 165 | 254 | 405 | 317 |
| Cash Conversion Cycle | — | 51 | 91 | 113 | 189 | 229 |
| Working Capital Days | — | 20 | 24 | 58 | 55 | -30 |
| ROCE % | — | — | 9 | 1 | -4 | -4 |

## Shareholding Pattern

### Quarterly

| Category | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Promoters | 70.6% | 70.6% | 70.6% | 70.6% | 70.6% | 70.6% | 70.6% | 70.6% | 70.6% | 70.6% | 70.6% | 70.6% |
| FIIs | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| DIIs | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Government | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Public | 26.23% | 26.09% | 25.29% | 25.62% | 25.48% | 25.45% | 25.92% | 26.11% | 26.11% | 26.18% | 26.26% | 26.21% |
| Others | 3.16% | 3.31% | 4.11% | 3.78% | 3.92% | 3.95% | 3.48% | 3.29% | 3.29% | 3.21% | 3.13% | 3.19% |
| No. of Shareholders | 7305 | 7055 | 6918 | 6868 | 6631 | 6468 | 6517 | 6508 | 6400 | 6273 | 6084 | 5952 |

## Technical Indicators

Derived from daily closing prices and recomputed each trading session; values move with the market.

- **Overall Signal:** Strong Buy
- **Buy / Neutral / Sell:** 12 / 3 / 4

### Moving Averages — summary: **Strong Buy**

| Indicator | Value | Signal |
| --- | --- | --- |
| SMA (10) | 34.21 | Buy |
| EMA (10) | 34.09 | Buy |
| SMA (20) | 30.88 | Buy |
| EMA (20) | 32.81 | Buy |
| SMA (50) | 32.62 | Buy |
| EMA (50) | 32.15 | Buy |
| SMA (100) | 31.51 | Buy |
| EMA (100) | 31.16 | Buy |
| SMA (200) | 28.53 | Buy |
| EMA (200) | 30.14 | Buy |

### Oscillators — summary: **Sell**

| Indicator | Value | Signal |
| --- | --- | --- |
| RSI (14) | 66.76 | Neutral |
| MACD (12,26,9) | 1.14 | Buy |
| Stochastic (14,3,3) | 98.4 | Sell |
| ADX (14) | 21.16 | Neutral |
| Williams %R (14) | -4.81 | Sell |
| ATR (14) | 1.24 | High Volatility |
| ROC (12) | 28.65 | Buy |
| Stoch RSI (14) | 100 | Sell |
| UO (7,14,28) | 84.89 | Sell |

## Filings & Documents

### Exchange Filings & Announcements

| Date | Document |
| --- | --- |
| 2026-09-07 | [Board Meeting Outcome for Board Meeting Outcome For Board Meeting Outcome For Intimation Of AGM](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5832788e-fec0-4338-bfaa-2afc20104d08.pdf) |
| 2026-09-07 | [Intimation Of 20Th Annual General Meeting](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6aa02265-d976-4f6b-bda4-e24efbc585a0.pdf) |
| 2026-09-07 | [Intimation Of Book Closure](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f86e608f-fa72-468c-8bb9-d6e1cb0f5fec.pdf) |
| 2026-09-07 | [Notice Of 20Th AGM Of The Company On Wednesday 30Th September 2026 At 12 :00 Noon. (IST) Through Video Conferencing (VC) / Other Audio Visual Means (OA VM).](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0a74d358-a57d-488e-adba-23035f9b28ce.pdf) |
| 2026-09-07 | [Reg. 34 (1) Annual Report.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3e689810-d596-406b-b5fd-ab2aa09b1979.pdf) |
| 2026-08-14 | [Board Meeting Outcome for Board Meeting Outcome For Submission Of Standalone And Consolidated Unaudited Financial Results For The Quarter Ended On 30.06.2026 Under Regulation 33 Of The SEBI (LODR) Regulations 2015](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7a900f30-7e23-4e88-af56-be77291f29f2.pdf) |
| 2026-08-07 | [Board Meeting Intimation for Consideration And Approval Of Standalone & Consolidated Unaudited Financial Results For The Quarter Ended 30-06-2026.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=191667ff-dbf3-47f3-a965-a7a00b9ab438.pdf) |
| 2026-07-21 | [Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=208cde8b-0429-4d8b-beea-712dfe22024f.pdf) |
| 2026-06-19 | [Closure of Trading Window](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d2741db6-4cfa-4a6e-acc7-f0dde760a9bf.pdf) |
| 2026-06-05 | [Announcement under Regulation 30 (LODR)-Newspaper Publication](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=df520232-8d95-47d6-8307-640e8f7a59d0.pdf) |

### Results & Financial Statements

| Date | Document |
| --- | --- |
| 2026-08-14 | [Submission Of Standalone And Consolidated Unaudited Financial Results For The Quarter Ended On 30.06.2026 Under Regulation 33 Of The SEBI (LODR) Regulations 2015](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9df11edf-375d-4496-b8cc-d3aea09482a0.pdf) |
| 2026-05-30 | [Results - 31.03.2026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=12cc8b9e-5b4a-44d1-8d92-b275ed52c389.pdf) |
| 2026-02-14 | [Approval Of Unaudited Financial Results For The Quarter And Nine Months Ended 31-12-2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=02b39ad5-4c98-457e-ab73-812369fca131.pdf) |
| 2025-11-14 | [Unaudited Financial Results For The Quarter And Half Year Ended 30-09-2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1c3df6bf-7efc-487b-91fd-c5afb3e0017e.pdf) |
| 2025-08-14 | [Standalone & Consolidated Unaudited Financial Results For The Quarter Ended 30.06.2025.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2c09173f-ff32-4db3-a7c5-b10aa9b89ace.pdf) |
| 2025-05-30 | [Financial Year Results For The Year Ended 31.03.2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b5058c4d-6970-414b-98ae-4e964657fb61.pdf) |
| 2025-02-14 | [UNAUDITED FINANCIAL RESULTS FOR Q.E. 31-12-2024](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=97c08b48-798e-428e-bf15-5760dfa2cca6.pdf) |
| 2024-11-14 | [Financial Results For Quarter And Half Year Ended 30.09.2024.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7c7831f2-19a7-417f-bdb6-72688a0d6688.pdf) |
| 2024-08-14 | [Unaudited Standalone And Consolidated Financial Result For Quarter Ended As At 30.06.2024](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=55af1f92-5051-424e-8629-be484862c0c6.pdf) |
| 2024-05-30 | [Financial Result For Quarter And Year Ended As At 31.03.2024](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0e3209d6-6000-4cb8-8a4e-2a7675eaa176.pdf) |

### Other Documents

| Date | Document |
| --- | --- |
| 9 March 2026 - Promoter Sudeesh gifted 2,80,941 shares (2.65%) to brother Suresh on March 6, 2026. | [General Updates 9 March 2026 - Promoter Sudeesh gifted 2,80,941 shares (2.65%) to brother Suresh on March 6, 2026.](https://nsearchives.nseindia.com/corporate/PELATRO_09032026215803_Intimation_to_NSE_under_Reg_30_of_LODR_-_Reg_29_2_.pdf) |
| 9 March 2026 - Promoter gift transfer of 280,941 shares (2.65%) from Sudeesh to Suresh on March 6, 2026. | [General Updates 9 March 2026 - Promoter gift transfer of 280,941 shares (2.65%) from Sudeesh to Suresh on March 6, 2026.](https://nsearchives.nseindia.com/corporate/PELATRO_09032026215634_Intimation_to_NSE_under_Reg_30_of_LODR_-_Reg_10_6_.pdf) |
| 9 March 2026 - Pelatro attended virtual Arihant Capital Bharat Connect conference on March 9, 2026; no UPSI shared. | [Analysts/Institutional Investor Meet/Con. Call Updates 9 March 2026 - Pelatro attended virtual Arihant Capital Bharat Connect conference on March 9, 2026; no UPSI shared.](https://nsearchives.nseindia.com/corporate/PELATRO_09032026214559_Outcome_of_Investor_Meeting_held_on_March_09_2026.pdf) |
| 9 February 2026 - Ms. Khushboo Sharma resigns as Company Secretary and Compliance Officer, effective February 09, 2026. | [Resignation 9 February 2026 - Ms. Khushboo Sharma resigns as Company Secretary and Compliance Officer, effective February 09, 2026.](https://nsearchives.nseindia.com/corporate/PELATRO_09022026180310_Intimation_to_NSE_on_Resignation_of_CS.pdf) |
| 8 February 2026 - Q3 FY26 transcript: 9M revenue INR99.12 Cr (+62%); Q3 revenue INR38.38 Cr (+69%); EBITDA margin 22.6% | [Analysts/Institutional Investor Meet/Con. Call Updates 8 February 2026 - Q3 FY26 transcript: 9M revenue INR99.12 Cr (+62%); Q3 revenue INR38.38 Cr (+69%); EBITDA margin 22.6%](https://nsearchives.nseindia.com/corporate/PELATRO_08022026130742_NSE_Upload_transcript05022026.pdf) |
| 6 Feb - Revised secretarial compliance report for FY2024-25; delayed share capital audit reconciliation for June and Sept 2024. | [Compliances-Reg.24(A)-Annual Secretarial Compliance 6 Feb - Revised secretarial compliance report for FY2024-25; delayed share capital audit reconciliation for June and Sept 2024.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/3598f6e8-ad9e-40a6-9c63-125cbbf2da55.pdf) |
| 5 February 2026 - Audio recording of Q3 FY26 results conference call posted on company website (Feb 05, 2026). | [Analysts/Institutional Investor Meet/Con. Call Updates 5 February 2026 - Audio recording of Q3 FY26 results conference call posted on company website (Feb 05, 2026).](https://nsearchives.nseindia.com/corporate/PELATRO_05022026202753_Earningscall05022026.pdf) |
| 5 Feb - Board meeting 14-Feb-2026 to approve Q3/9M FY2026 unaudited results (ended 31-Dec-2025); trading window closed. | [Board Meeting Intimation for Consideration And Approval Of The Unaudited Standalone And Consolidated Financial Results Of The Company For The Quarter Ended And Nine Months Ended On 31St December, 2025. 5 Feb - Board meeting 14-Feb-2026 to approve Q3/9M FY2026 unaudited results (ended 31-Dec-2025); trading window closed.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/311a60df-ddad-43b2-965e-24714a06368c.pdf) |
| 3 March 2026 - Pelatro Limited has informed about Schedule of Analyst/Institutional Investor meet | [Analysts/Institutional Investor Meet/Con. Call Updates 3 March 2026 - Pelatro Limited has informed about Schedule of Analyst/Institutional Investor meet](https://nsearchives.nseindia.com/corporate/PELATRO_03032026113238_Intimation_to_NSE_on_Investor_Meeting_under_Reg_30_of_LODR.pdf) |
| 3 February 2026 - Q3 & 9M FY26 results: Revenue ₹9,912.75 lakh (+62%), EBITDA ₹2,237.91 lakh (+73%), PAT ₹1,367.51 lakh (+66.7%). | [Investor Presentation 3 February 2026 - Q3 & 9M FY26 results: Revenue ₹9,912.75 lakh (+62%), EBITDA ₹2,237.91 lakh (+73%), PAT ₹1,367.51 lakh (+66.7%).](https://nsearchives.nseindia.com/corporate/PELATRO_03022026162146_NSEUpload_Press_releaseandInvestorpresentation.pdf) |

### Earnings Call Documents

| Date | Document |
| --- | --- |
| Sep 2021 | [Concall - Sep 2021](https://www.bseindia.com/xml-data/corpfiling/AttachHis/daff7c2c-5e1b-4d4a-8db6-6caf955063b9.pdf) |
| Oct 2021 | [Concall - Oct 2021](https://www.bseindia.com/xml-data/corpfiling/AttachHis/559bd3dc-560f-4ef8-a776-050a722318c8.pdf) |
| Nov 2025 | [Concall - Nov 2025](https://nsearchives.nseindia.com/corporate/PELATRO_07112025155349_InvestorPPTuploadSep302025.pdf) |
| Nov 2025 | [Concall - Nov 2025](https://nsearchives.nseindia.com/corporate/PELATRO_26112025164741_Transcriptnseupload241125concallsigned.pdf) |
| Nov 2025 | [Concall - Nov 2025](https://nsearchives.nseindia.com/corporate/PELATRO_26112025163336_Transcriptnseupload241125concall.pdf) |
| Nov 2024 | [Concall - Nov 2024](https://nsearchives.nseindia.com/corporate/PELATRO_04112024145704_Investor_deck_Neaps_upload-.pdf) |
| May 2025 | [Concall - May 2025](https://nsearchives.nseindia.com/corporate/PELATRO_14052025165144_Earnings_Call_09052025Nseuploadfile.pdf) |
| Jun 2019 | [Concall - Jun 2019](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=67306615-9d78-47e8-aac9-d7dc8b0d3816.pdf) |
| Jun 2019 | [Concall - Jun 2019](https://www.bseindia.com/xml-data/corpfiling/AttachHis/67306615-9d78-47e8-aac9-d7dc8b0d3816.pdf) |
| Feb 2022 | [Concall - Feb 2022](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d6cda1b5-0241-4fc7-9179-20141a6d9c48.pdf) |

### Annual Reports

| Date | Document |
| --- | --- |
| from nse | [Financial Year 2025 from nse](https://archives.nseindia.com/annual_reports/SME_AR_26562_PELATRO_2024_2025_A_17062025162552.pdf) |
| from bse | [Annual Report 2025 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/6fbc5808-8c45-4d3b-8e75-1712b9c54705.pdf) |
| from bse | [Annual Report 2024 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/5daa94cf-4041-4ee6-a4c9-60dc41669f07.pdf) |
| from bse | [Annual Report 2023 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/982affb3-57b3-4058-b47a-6286c73ca4f9.pdf) |
| from bse | [Annual Report 2022 from bse](https://www.bseindia.com/bseplus/AnnualReport/540694/76278540694.pdf) |
| from bse | [Annual Report 2021 from bse](https://www.bseindia.com/bseplus/AnnualReport/540694/72669540694.pdf) |
| from bse | [Annual Report 2020 from bse](https://www.bseindia.com/bseplus/AnnualReport/540694/68210540694.pdf) |
| from bse | [Annual Report 2019 from bse](https://www.bseindia.com/bseplus/AnnualReport/540694/5406940319.pdf) |
| from bse | [Annual Report 2018 from bse](https://www.bseindia.com/bseplus/AnnualReport/540694/5406940318.pdf) |

### Investor Presentations

| Date | Document |
| --- | --- |
| 2022-08-14 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=23eece97-0caf-4fec-add2-d2d092b92c7d.pdf) |
| 2021-10-26 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=559bd3dc-560f-4ef8-a776-050a722318c8.pdf) |
| 2021-09-06 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=daff7c2c-5e1b-4d4a-8db6-6caf955063b9.pdf) |

---

Provenance differs by section. Financial statements, shareholding and filings are as reported in company disclosures to NSE/BSE/SEBI. Price, volume and 52-week levels are exchange market data. Technical indicators are computed by Tapetide from daily closing prices. The Tapetide Score is Tapetide's own analysis. Analyst ratings are third-party estimates, not company statements. All figures are for research and information only and are not investment advice. Generated 2026-09-13T19:29:15.891Z.